Can you generate antibodies against veterinary targets?

Absolutely. We use one of our three discovery platforms — phage display, hybridoma, or single B cell — depending on your project’s needs and constraints.

Do you work with antigens from animal pathogens (viruses, bacteria, parasites)?

Yes. We work with any antigen type, including cells, peptides, proteins, small molecules, DNA constructs, VLPs, and nanodiscs. This allows us to tackle membrane proteins, toxic antigens, highly conserved targets, and low-immunogenic molecules. All projects are backed by the strongest guarantees on the market — if we don’t deliver, you don’t pay.

Can you generate antibodies against proteins from specific animal species?

Yes. Our AI specization platform allows us to convert any antibody to virtually any target species, while simultaneously optimizing developability.

Can you generate antibodies against challenging antigens, such as membrane proteins?

Yes. Our platforms are designed to handle the most difficult targets — membrane proteins, toxic antigens, highly conserved sequences, and low-immunogenic molecules — across any antigen format

What antibody formats can you generate?

We offer reformatting into any desired format, including VHH, Fab, ScFv, bispecifics, Fc fusions, and more — tailored to your application and budget.

What is the typical timeline for antibody development?

Timelines vary depending on the project and platform. As a benchmark, a phage display animal health project typically delivers a lead candidate in as little as 4 weeks.

Can you provide large-scale antibody production if needed?

Yes. We offer stable cell line development for long-term production needs. For projects with tighter budgets, we can also provide large-scale transient production in bioreactors as a cost-effective alternative.

Can the screening strategy be customized for our project?

Always. Every project is fully custom — strategy, screening, and deliverables are designed around your specific target, species, timeline, and budget.

Will we receive regular project updates?

Yes. You’ll be assigned a dedicated PhD-level expert who will keep you informed at every stage of the project.

Can you support further antibody optimization or engineering?

Yes. We offer a full range of optimization and engineering services, including AI-driven affinity maturation and developability optimization, Fc modifications, ADC development, bispecific antibody engineering, and CAR-T cell development.

What makes your platform particularly suitable for animal health projects?

Our species-specific phage display libraries cover a broad panel of veterinary species without requiring a specization step. And when specization is needed, our proprietary AI platform converts any lead antibody — including human therapeutics — to your target species while optimizing developability in a single step.

Why should we choose Proteogenix over other CROs?

We understand the unique challenges of veterinary antibody development — and we have the track record to prove it. Our animal health services are fully guaranteed on a no-win, no-fee basis, and all generated IP belongs to you. We specialize in complex projects and never back down from a challenge.

Custom antibodies services animal health

Custom antibodies for animal health

Q: Do you have specialized antibody libraries for veterinary applications?

Yes. We maintain one of the largest species-specific library panels in the industry, covering companion animals (dog, cat, rabbit) and livestock (horse, swine, cattle) — with cattle-specific libraries being particularly rare in the field.

Veterinary antibodies services for Every Species, Every Budget, Every Timeline

No win, no fee

Many species of pets and cattle covered by our phage display libraries

Specization using our proprietary AI: AIxplore®

Get your Custom Veterinary Antibodies for your Target Species in 4 weeks

Custom veterinary antibodies target species

From target fully IP-free lead candidate in as little as 4 weeks, our phage display platform is purpose-built for animal health. We maintain one of the largest species-specific library panels in the industry: covering companion animals (dog, cat, rabbit) and livestock (horse, swine, cattle).

For cost-conscious projects, our VHH phage display library offer an increasingly popular alternative — VHHs are significantly cheaper to produce, making them a smart choice for veterinary applications with tighter budgets. Throughout the process, your dedicated PhD expert will guide you through strategy design to navigate your species, timeline, and budget constraints.

Explore our phage display services Discuss your project with our experts

Take a look at our pet & cattle ScFv/Fab antibody libraries

Breeds of dogs

Breeds of cats

Breeds of rabbits

Clones per library on average

Custom dog monoclonal antibodies
- Beagle
- German Shepherd
- Labrador
- English Coonhound
- Great Dane
- Chinese Rural Dog
Custom cat monoclonal antibodies
- Ragdoll
- Maine Coon
- Persian
- Domestic Shorthair
- Domestic Longhair
- American Shorthair
- Siamese
- Bengal
Custom rabbit monoclonal antibodies
- New Zealand White
- Himalayan
- Japanese White
- Hare
Horse Antibodies
Swine Antibodies
Cow Antibodies

Do you want more information on our phage display libraries?

Contact our Experts

Get fully guarenteed antibodies for Any Species in 3–4 Weeks with our AI specization platform

Adapt any lead candidate to your target species
Convert human therapeutics to any animal species
Cross-species conversion, from any starting point to any target

XtenCHO™ Race the Gold Standard for Complex Protein Expression

Stop wasting time and budget on trial-and-error wet lab testing. Our proprietary AI models — trained specifically on veterinary targets and complex animal health projects — prioritize the most promising leads upfront, so you only invest resources where it counts and keep full ownership of every result. Our unique two-in-one approach simultaneously optimizes developability while performing specization, shortening your development timeline whether you’re adapting a human therapeutic or switching between species. Throughout the process, our bioinformatics experts help you interpret results and define the best path forward for streamlined wet lab validation.

Talk to our experts

Fast-track your project with our Two-in-One service: optimize developability during specization

Guidance and experience on animal health through your entire Custom veterinary antibody development

Antibody Discovery Platforms

High throughput antibody production platform

Antibody Optimization Services

Recombinant antibody production services

Antibody characterization services

Custom Cell Line Development

Trusted by Researchers and Innovators Worldwide

It was a real pleasure working with the Proteogenix team. Everything went very smoothly, the coordination was close and efficient, and they were always quick to respond to any doubts or questions. We truly appreciated how attentive they were throughout the entire process; at all times, we felt the communication was fluid and proactive. The delivery timelines were perfectly met, which made the collaboration even more seamless. I’d be happy to work together with them again in the future.

Jose Luis Donoso Muñoz, Scientist at LETI PHARMA

Publications

Patent

ProteoGenix’s Dog Phage Display Library

Mazouari, K. E. & Abnomx BV. (2022). WO2023161448A1 – Human-like Target-binding proteins – Google Patents (Patent N^o WO2023161448A1). https://patents.google.com/patent/WO2023161448A1/

See the patent

Kick start your veterinary project

With years of experience in veterinary antibody development, our experts have guided countless programs toward the right strategy — saving time, reducing costs, and avoiding dead ends. Not sure which technology fits your project? Our practical decision guide helps you choose from day one. research and therapeutic programs toward the right strategy — saving time, reducing costs:

Read our decision guide Get advice from our Experts

Related Services

Custom antibody services Recombinant antibody production services

FAQ

Yes. We work with any antigen type, including cells, peptides, proteins, small molecules, DNA constructs, VLPs, and nanodiscs. This allows us to tackle membrane proteins, toxic antigens, highly conserved targets, and low-immunogenic molecules. All projects are backed by the strongest guarantees on the market — if we don’t deliver, you don’t pay.
Our species-specific phage display libraries cover a broad panel of veterinary species without requiring a specization step. And when specization is needed, our proprietary AI platform converts any lead antibody — including human therapeutics — to your target species while optimizing developability in a single step.
We understand the unique challenges of veterinary antibody development — and we have the track record to prove it. Our animal health services are fully guaranteed on a no-win, no-fee basis, and all generated IP belongs to you. We specialize in complex projects and never back down from a challenge.